Telix, A Biopharmaceutical Company, Announces That Health Canada Has Approved Illuccix [Kit For The Preparation Of Gallium (68Ga) Gozetotide Injection] For Use In Staging And Re-Staging Intermediate And High-Risk Prostate Cancer And Localizing Tumour Tissue In Recurrent Prostate Cancer.Illuccix [Kit For The Preparation Of Gallium (68Ga) Gozetotide Injection], After Radiolabeling With Gallium (68Ga), Is Indicated For Use With The Positron Emission Tomography (Pet) Of Prostate Specific Membrane Antigen (Psma) Positive Lesions In Men With Prostate Cancer: With Suspected Metastasis Who Are Suitable For Initial Definitive Therapy; With Suspected Recurrence With Elevated Serum Prostate Specific Antigen (Psa) Level.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!